NASDAQ
CRISPR Therapeutics AG - Common Shares (CRSP)
♥ 617 Thanks from members
CRISPR Therapeutics (CRSP) displays a polarized net sentiment, balancing robust retail optimism and commercial momentum from CASGEVY with institutional concerns regarding profitability, lagging web traffic, and an underperforming share price relative to broader biotech indexes.